Traumatic brain injury (TBI) remains a major public health problem globally. Presently, there is no way to restore cognitive deficits caused by TBI. In this study, we seek to evaluate the effect of statins (simvastatin and atorvastatin) on the spatial learning and neurogenesis in rats subjected to controlled cortical impact. Rats were treated with atorvastatin and simvastatin 1 day after TBI and daily for 14 days. Morris water maze tests were performed during weeks 2 and 5 after TBI. Bromodeoxyuridine (BrdU; 50 mg/kg) was intraperitoneally injected 1 day after TBI and daily for 14 days. Brain tissue was processed for immunohistochemical staining to identify newly generated cells and vessels. Our data show that (1) treatment of TBI with statins improves spatial learning on days 31-35 after onset of TBI; (2) in the non-neurogenic region of the hippocampal CA3 region, statin treatment reduces the neuronal loss after TBI, demonstrating the neuroprotective effect of statins; (3) in the neurogenic region of the dentate gyrus, treatment of TBI with statins enhances neurogenesis; (4) statin treatment augments TBI-induced angiogenesis; and (5) treatment with simvastatin at the same dose provides a therapeutic effect superior to treatment with atorvastatin. These results suggest that statins may be candidates for treatment of TBI.
Key Points
Question
Can machine learning models predict patient risks of postoperative complications related to pneumonia, acute kidney injury, deep vein thrombosis, delirium, and pulmonary embolism?
Findings
In a cohort study of 111 888 operations at a large academic medical center, machine learning algorithms exhibited high areas under the receiver operating characteristic curve for predicting the risk of postoperative complications related to pneumonia, acute kidney injury, deep vein thrombosis, pulmonary embolism, and delirium.
Meaning
These findings suggest that machine learning models using preoperative and intraoperative data can predict postoperative complications and generate reliable and clinically meaningful interpretations for supporting clinical decisions along the perioperative care continuum.
Background
Episodes of patient deterioration on hospital units are expected to increasingly contribute to morbidity and healthcare costs.
Objective
To determine if real-time alerts sent to the rapid response team (RRT) improved patient care.
Design
Randomized, controlled trial.
Setting
Eight medicine units (Barnes-Jewish Hospital).
Patients
571 patients.
Intervention
Real-time alerts generated by a validated deterioration algorithm were sent real-time to the RRT (intervention) or hidden (control).
Measurements
ICU transfer, hospital mortality, hospital duration.
Results
ICU transfer (17.8% versus 18.2%; odds ratio, 0.972; 95% CI, 0.635–1.490) and hospital mortality (7.3% versus 7.7%; odds ratio, 0.947; 95% CI, 0.509–1.764) were similar for the intervention and control groups. The number of patients requiring transfer to a nursing home or long-term acute care hospital was similar for patients in the intervention and control groups (26.9% versus 26.3%; odds ratio, 1.032; 95% CI, 0.712–1.495). Hospital duration [8.4 ± 9.5 days versus 9.4 ± 11.1 days; P = 0.038] was statistically shorter for the intervention group. The number of RRT calls initiated by the primary care team was similar for the intervention and control groups (19.9% versus 16.5%; odds ratio, 1.260; 95% CI, 0.823–1.931).
Conclusions
Real-time alerts sent to the RRT did not reduce ICU transfers, hospital mortality, or the need for subsequent long term care, however hospital length of stay was modestly reduced.
These data demonstrate that at the doses used, EPO and CEPO are equally effective in enhancing spatial learning and promoting neural plasticity after TBI.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.